PyTorchKR Papers

최신 논문

총 66편
태그·기간 등 상세 필터

카테고리 탐색

로그인 후 이 태그 구독

arXiv:2207.13921공식 코드 · Papers with Code

HelixFold-Single: MSA-free Protein Structure Prediction by Using Protein Language Model as an Alternative

AI-based protein structure prediction pipelines, such as AlphaFold2, have achieved near-experimental accuracy. These advanced pipelines mainly rely on Multiple Sequence Alignments (MSAs) as inputs to learn the co-evolution information from the homologous sequences. Nonetheless, searching MSAs from protein databases is time-consuming, usually taking dozens of minutes. Consequently, we attempt to explore the limits of fast protein structure prediction by using only primary sequences of proteins. HelixFold-Single is proposed to combine a large-scale protein language model with the superior geometric learning capability of AlphaFold2. Our proposed method, HelixFold-Single, first pre-trains a large-scale protein language model (PLM) with thousands of millions of primary sequences utilizing the self-supervised learning paradigm, which will be used as an alternative to MSAs for learning the co-evolution information. Then, by combining the pre-trained PLM and the essential components of AlphaFold2, we obtain an end-to-end differentiable model to predict the 3D coordinates of atoms from only the primary sequence. HelixFold-Single is validated in datasets CASP14 and CAMEO, achieving competitive accuracy with the MSA-based methods on the targets with large homologous families. Furthermore, HelixFold-Single consumes much less time than the mainstream pipelines for protein structure prediction, demonstrating its potential in tasks requiring many predictions. The code of HelixFold-Single is available at https://github.com/PaddlePaddle/PaddleHelix/tree/dev/apps/protein_folding/helixfold-single, and we also provide stable web services on https://paddlehelix.baidu.com/app/drug/protein-single/forecast.

arXiv:2204.07110공식 코드 · Papers with Code

Generative power of a protein language model trained on multiple sequence alignments

Computational models starting from large ensembles of evolutionarily related protein sequences capture a representation of protein families and learn constraints associated to protein structure and function. They thus open the possibility for generating novel sequences belonging to protein families. Protein language models trained on multiple sequence alignments, such as MSA Transformer, are highly attractive candidates to this end. We propose and test an iterative method that directly employs the masked language modeling objective to generate sequences using MSA Transformer. We demonstrate that the resulting sequences score as well as natural sequences, for homology, coevolution and structure-based measures. For large protein families, our synthetic sequences have similar or better properties compared to sequences generated by Potts models, including experimentally-validated ones. Moreover, for small protein families, our generation method based on MSA Transformer outperforms Potts models. Our method also more accurately reproduces the higher-order statistics and the distribution of sequences in sequence space of natural data than Potts models. MSA Transformer is thus a strong candidate for protein sequence generation and protein design.

arXiv:2204.04213공식 코드 · Papers with Code

Structure-aware Protein Self-supervised Learning

Protein representation learning methods have shown great potential to yield useful representation for many downstream tasks, especially on protein classification. Moreover, a few recent studies have shown great promise in addressing insufficient labels of proteins with self-supervised learning methods. However, existing protein language models are usually pretrained on protein sequences without considering the important protein structural information. To this end, we propose a novel structure-aware protein self-supervised learning method to effectively capture structural information of proteins. In particular, a well-designed graph neural network (GNN) model is pretrained to preserve the protein structural information with self-supervised tasks from a pairwise residue distance perspective and a dihedral angle perspective, respectively. Furthermore, we propose to leverage the available protein language model pretrained on protein sequences to enhance the self-supervised learning. Specifically, we identify the relation between the sequential information in the protein language model and the structural information in the specially designed GNN model via a novel pseudo bi-level optimization scheme. Experiments on several supervised downstream tasks verify the effectiveness of our proposed method.The code of the proposed method is available in \url{https://github.com/GGchen1997/STEPS_Bioinformatics}.

arXiv:2202.03632공식 코드 · Papers with Code

ECRECer: Enzyme Commission Number Recommendation and Benchmarking based on Multiagent Dual-core Learning

Enzyme Commission (EC) numbers, which associate a protein sequence with the biochemical reactions it catalyzes, are essential for the accurate understanding of enzyme functions and cellular metabolism. Many ab-initio computational approaches were proposed to predict EC numbers for given input sequences directly. However, the prediction performance (accuracy, recall, precision), usability, and efficiency of existing methods still have much room to be improved. Here, we report ECRECer, a cloud platform for accurately predicting EC numbers based on novel deep learning techniques. To build ECRECer, we evaluate different protein representation methods and adopt a protein language model for protein sequence embedding. After embedding, we propose a multi-agent hierarchy deep learning-based framework to learn the proposed tasks in a multi-task manner. Specifically, we used an extreme multi-label classifier to perform the EC prediction and employed a greedy strategy to integrate and fine-tune the final model. Comparative analyses against four representative methods demonstrate that ECRECer delivers the highest performance, which improves accuracy and F1 score by 70% and 20% over the state-of-the-the-art, respectively. With ECRECer, we can annotate numerous enzymes in the Swiss-Prot database with incomplete EC numbers to their full fourth level. Take UniPort protein "A0A0U5GJ41" as an example (1.14.-.-), ECRECer annotated it with "1.14.11.38", which supported by further protein structure analysis based on AlphaFold2. Finally, we established a webserver (https://ecrecer.biodesign.ac.cn) and provided an offline bundle to improve usability.

arXiv:2111.06023

HMD-AMP: Protein Language-Powered Hierarchical Multi-label Deep Forest for Annotating Antimicrobial Peptides

Identifying the targets of an antimicrobial peptide is a fundamental step in studying the innate immune response and combating antibiotic resistance, and more broadly, precision medicine and public health. There have been extensive studies on the statistical and computational approaches to identify (i) whether a peptide is an antimicrobial peptide (AMP) or a non-AMP and (ii) which targets are these sequences effective to (Gram-positive, Gram-negative, etc.). Despite the existing deep learning methods on this problem, most of them are unable to handle the small AMP classes (anti-insect, anti-parasite, etc.). And more importantly, some AMPs can have multiple targets, which the previous methods fail to consider. In this study, we build a diverse and comprehensive multi-label protein sequence database by collecting and cleaning amino acids from various AMP databases. To generate efficient representations and features for the small classes dataset, we take advantage of a protein language model trained on 250 million protein sequences. Based on that, we develop an end-to-end hierarchical multi-label deep forest framework, HMD-AMP, to annotate AMP comprehensively. After identifying an AMP, it further predicts what targets the AMP can effectively kill from eleven available classes. Extensive experiments suggest that our framework outperforms state-of-the-art models in both the binary classification task and the multi-label classification task, especially on the minor classes.The model is robust against reduced features and small perturbations and produces promising results. We believe HMD-AMP contributes to both the future wet-lab investigations of the innate structural properties of different antimicrobial peptides and build promising empirical underpinnings for precise medicine with antibiotics.

arXiv:2004.10177공식 코드 · Papers with Code

Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity

Messenger RNA (mRNA) vaccines are being used for COVID-19, but still suffer from the critical issue of mRNA instability and degradation, which is a major obstacle in the storage, distribution, and efficacy of the vaccine. Previous work showed that optimizing secondary structure stability lengthens mRNA half-life, which, together with optimal codons, increases protein expression. Therefore, a principled mRNA design algorithm must optimize both structural stability and codon usage to improve mRNA efficiency. However, due to synonymous codons, the mRNA design space is prohibitively large, e.g., there are $\sim\!10^{632}$ mRNAs for the SARS-CoV-2 Spike protein, which poses insurmountable challenges to previous methods. Here we provide a surprisingly simple solution to this hard problem by reducing it to a classical problem in computational linguistics, where finding the optimal mRNA is akin to finding the most likely sentence among similar sounding alternatives. Our algorithm, named LinearDesign, takes only 11 minutes for the Spike protein, and can jointly optimize stability and codon usage. Experimentally, without chemical modification, our designs substantially improve mRNA half-life and protein expression in vitro, and dramatically increase antibody response by up to 23$\times$ in vivo, compared to the codon-optimized benchmark. Our work enables the exploration of highly stable and efficient designs that are previously unreachable and is a timely tool not only for vaccines but also for mRNA medicine encoding all therapeutic proteins (e.g., monoclonal antibodies and anti-cancer drugs).